SCHEMBL6774705

SCHEMBL6774705

Oc1ccccc1O[C@@H](CCc1ccc(-c2ccccc2F)cc1)N1CCC(O)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.37
UGCG Q16739 1/20 0.37
GBA2 Q9HCG7 1/20 0.37
DPP4 P27487 1/20 0.37
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
KCNH2 Q12809 4/20 0.36
TMEM97 Q5BJF2 4/20 0.36
SIGMAR1 Q99720 4/20 0.36
GRM2 Q14416 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
GRIA4 P48058 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
MAPKAPK2 P49137 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
OPRK1 P41145 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3892351 1.00 GBA1 (0.37) GBA1UGCGGBA2DPP4PPARG
SCHEMBL3892880 1.00 GBA1 (0.37) GBA1UGCGGBA2DPP4PPARG
SCHEMBL3958696 0.81 NPC1 (0.44) KCNH2
SCHEMBL3899545 0.81 NPC1 (0.44) KCNH2
SCHEMBL3888745 0.81 NPC1 (0.44) KCNH2
SCHEMBL3892465 0.75 NAAA (0.41) MEN1KMT2ASMN1; SMN2
SCHEMBL27478933 0.65 FFAR4 (0.43) MEN1KMT2AALDH1A1MAPTMAPKAPK2
SCHEMBL8220687 0.64 SLC18A3 (0.39) KCNH2SIGMAR1
SCHEMBL11807188 0.64 GRIA4 (0.55) PPARGPPARAGRM2MEN1KMT2A
SCHEMBL18559001 0.62 TDP1 (0.52) PPARGPPARAGRM2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0867183-B1 ARYLPIPERIDINOL AND ARYLPIPERIDINE DERIVATIVES AND DRUGS CONTAINING THE SAME DAIICHI SUNTORY PHARMA CO LTD (JP) 2004-10-06 EP disclosed
US-6706734-B2 ANTIISCHEMIC AGENTS; ANTICONVULSANTS; HEADACHES DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2004-03-16 US disclosed
US-20030130312-A1 Arylpiperidinol and arylpiperidine derivatives and pharmaceuticals containing the same ASUBIO PHARMA CO., LTD. (JP) 2003-07-10 US disclosed
US-6455549-B1 ANTIEPILEPTIC, ANTIISCHEMIC, AND ANTIMIGRAINE AGENTS; CALCIUM OVELOAD SUPPRESSANTS SUNTORY LIMITED (JP) 2002-09-24 US disclosed
EP-0867183-A1 ARYLPIPERIDINOL AND ARYLPIPERIDINE DERIVATIVES AND DRUGS CONTAINING THE SAME SUNTORY LIMITED (JP) 1998-09-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130312-A1 Arylpiperidinol and arylpiperidine derivatives and pharmaceuticals containing the same KCNH1, KCNH2, NPY1R GBA1 967/4885UGCG 2367/4885GBA2 811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.